BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kucera O, Cervinkova Z. Experimental models of non-alcoholic fatty liver disease in rats. World J Gastroenterol 2014; 20(26): 8364-8376 [PMID: 25024595 DOI: 10.3748/wjg.v20.i26.8364] [Cited by in CrossRef: 99] [Cited by in F6Publishing: 93] [Article Influence: 12.4] [Reference Citation Analysis]
Number Citing Articles
1 Freitas I, Boncompagni E, Tarantola E, Gruppi C, Bertone V, Ferrigno A, Milanesi G, Vaccarone R, Tira ME, Vairetti M. In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine- and Choline-Deficient Diet. Oxid Med Cell Longev 2016;2016:9307064. [PMID: 26881047 DOI: 10.1155/2016/9307064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhang Q, Tian F, Zhao J, Zhang H, Zhai Q, Chen W. The influence of dietary patterns on gut microbiome and its consequences for nonalcoholic fatty liver disease. Trends in Food Science & Technology 2020;96:135-44. [DOI: 10.1016/j.tifs.2019.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Tang B, Feng MJ, Xie JN, Zhang YX, Tan ZJ, Deng BX. Influence of lipid-lowering decoction on biochemical indexes in rats with nonalcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2015; 23(18): 2942-2946 [DOI: 10.11569/wcjd.v23.i18.2942] [Reference Citation Analysis]
4 Klaikeaw N, Wongphoom J, Werawatganon D, Chayanupatkul M, Siriviriyakul P. Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis. World J Hepatol 2020; 12(7): 363-377 [PMID: 32821335 DOI: 10.4254/wjh.v12.i7.363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
5 Arora M, Kutinová Canová N, Farghali H. mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174857] [Reference Citation Analysis]
6 Stygar D, Sawczyn T, Dulska A, Chełmecka E, Mielańczyk Ł, Matysiak N, Kukla M, Idzik M, Augustyniak J, Gabriel A, Karcz K, Jochem J. Ileal transposition helps to regulate plasma hepatokine levels in obese Zucker (Crl:ZUC(ORL)-Leprfa) rats. Sci Rep 2021;11:7774. [PMID: 33833309 DOI: 10.1038/s41598-021-87293-w] [Reference Citation Analysis]
7 Colin IM, Knoops B, Gérard AC. Incretin-induced changes in the transcriptome of skeletal muscles of fa/fa Zucker rat (ZFR) with obesity, without diabetes. Int J Obes (Lond) 2022. [PMID: 35383269 DOI: 10.1038/s41366-022-01114-2] [Reference Citation Analysis]
8 Berardo C, Di Pasqua LG, Cagna M, Richelmi P, Vairetti M, Ferrigno A. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. Int J Mol Sci 2020;21:E9646. [PMID: 33348908 DOI: 10.3390/ijms21249646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
9 Colin IM, Colin H, Dufour I, Gielen CE, Many MC, Saey J, Knoops B, Gérard AC. Extrapancreatic effects of incretin hormones: evidence for weight-independent changes in morphological aspects and oxidative status in insulin-sensitive organs of the obese nondiabetic Zucker rat (ZFR). Physiol Rep 2016;4:e12886. [PMID: 27511983 DOI: 10.14814/phy2.12886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Higarza SG, Arboleya S, Gueimonde M, Gómez-Lázaro E, Arias JL, Arias N. Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits. PLoS One 2019;14:e0223019. [PMID: 31539420 DOI: 10.1371/journal.pone.0223019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
11 Watanabe K, Ohta M, Takayama H, Tada K, Shitomi Y, Kawasaki T, Kawano Y, Endo Y, Iwashita Y, Inomata M. Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model. OBES SURG 2018;28:1532-9. [DOI: 10.1007/s11695-017-3052-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
12 Chen Z, Liu Y, Yang L, Liu P, Zhang Y, Wang X. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway. Immunol Lett 2020;222:40-8. [PMID: 32194141 DOI: 10.1016/j.imlet.2020.03.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
13 Ali MH, Messiha BA, Abdel-Latif HA. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats. Pharm Biol. 2016;54:1198-1208. [PMID: 26134756 DOI: 10.3109/13880209.2015.1060247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
14 Toppo E, Sylvester Darvin S, Esakkimuthu S, Buvanesvaragurunathan K, Ajeesh Krishna T, Antony Caesar S, Stalin A, Balakrishna K, Pandikumar P, Ignacimuthu S, Al-dhabi N. Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models. Biomedicine & Pharmacotherapy 2018;107:979-88. [DOI: 10.1016/j.biopha.2018.08.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
15 Palladini G, Ferrigno A, Di Pasqua LG, Berardo C, Rizzo V, Perlini S, Vairetti M. Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease. PLoS One 2020;15:e0243179. [PMID: 33306695 DOI: 10.1371/journal.pone.0243179] [Reference Citation Analysis]
16 Vargas-pozada EE, Ramos-tovar E, Acero-hernández C, Cardoso-lezama I, Galindo-gómez S, Tsutsumi V, Muriel P. Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100671] [Reference Citation Analysis]
17 Thompson JA, Krajnak K, Johnston RA, Kashon ML, McKinney W, Fedan JS. High-fat western diet-consumption alters crystalline silica-induced serum adipokines, inflammatory cytokines and arterial blood flow in the F344 rat. Toxicol Rep 2022;9:12-21. [PMID: 34976743 DOI: 10.1016/j.toxrep.2021.12.001] [Reference Citation Analysis]
18 Zhang Y, Xiang D, Hu X, Ruan Q, Wang L, Bao Z. Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing. Annals of Hepatology 2020;19:302-12. [DOI: 10.1016/j.aohep.2019.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
19 Pandey A, Raj P, Goru SK, Kadakol A, Malek V, Sharma N, Gaikwad AB. Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway. Pharmacol Rep 2017;69:666-72. [PMID: 28527877 DOI: 10.1016/j.pharep.2017.02.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
20 Xu H, Zhou Y, Liu Y, Ping J, Shou Q, Chen F, Ruo R. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis. J Endocrinol 2016;229:133-44. [PMID: 26941037 DOI: 10.1530/JOE-15-0409] [Cited by in Crossref: 55] [Cited by in F6Publishing: 28] [Article Influence: 9.2] [Reference Citation Analysis]
21 Zhao W, Liu L, Wang Y, Mao T, Li J. Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease. Exp Ther Med 2016;11:183-90. [PMID: 26889237 DOI: 10.3892/etm.2015.2846] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
22 Guo X, Liu J, You L, Li G, Huang Y, Li Y. Association between adiponectin polymorphisms and the risk of colorectal cancer. Genet Test Mol Biomarkers 2015;19:9-13. [PMID: 25489716 DOI: 10.1089/gtmb.2014.0238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
23 Di Pasqua LG, Berardo C, Rizzo V, Richelmi P, Croce AC, Vairetti M, Ferrigno A. MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters. Mol Cell Biochem 2016;419:147-55. [PMID: 27357826 DOI: 10.1007/s11010-016-2758-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
24 Haldrup D, Heebøll S, Thomsen KL, Andersen KJ, Meier M, Mortensen FV, Nyengaard JR, Hamilton-Dutoit S, Grønbæk H. Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis. World J Hepatol 2018; 10(1): 8-21 [PMID: 29399274 DOI: 10.4254/wjh.v10.i1.8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Fisch J, Feistauer V, de Moura AC, Silva AO, Bollis V, Porawski M, Almeida S, Guedes RP, Barschak AG, Giovenardi M. Maternal feeding associated to post-weaning diet affects metabolic and behavioral parameters in female offspring. Physiol Behav 2019;204:162-7. [PMID: 30802509 DOI: 10.1016/j.physbeh.2019.02.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 Königshofer P, Brusilovskaya K, Schwabl P, Reiberger T. Animal models of portal hypertension. Biochim Biophys Acta Mol Basis Dis 2019;1865:1019-30. [PMID: 30055295 DOI: 10.1016/j.bbadis.2018.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Vázquez-velasco M, González-torres L, García-fernández RA, Méndez MT, Bastida S, Benedí J, González-muñoz MJ, Sánchez-muniz FJ. Glucomannan or Glucomannan Plus Spirulina-Enriched Squid-Surimi Diets Reduce Histological Damage to Liver and Heart in Zucker fa/fa Rats Fed a Cholesterol-Enriched and Non-Cholesterol-Enriched Atherogenic Diet. Journal of Medicinal Food 2017;20:618-25. [DOI: 10.1089/jmf.2016.0157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
28 Croce AC, Bottiroli G. Lipids: Evergreen autofluorescent biomarkers for the liver functional profiling. Eur J Histochem 2017;61:2808. [PMID: 28735528 DOI: 10.4081/ejh.2017.2808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
29 Carbajo-Pescador S, Porras D, García-Mediavilla MV, Martínez-Flórez S, Juarez-Fernández M, Cuevas MJ, Mauriz JL, González-Gallego J, Nistal E, Sánchez-Campos S. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease. Dis Model Mech 2019;12:dmm039206. [PMID: 30971408 DOI: 10.1242/dmm.039206] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
30 Dankel SN, Bjørndal B, Lindquist C, Grinna ML, Rossmann CR, Bohov P, Nygård O, Hallström S, Strand E, Berge RK. Hepatic Energy Metabolism Underlying Differential Lipidomic Responses to High-Carbohydrate and High-Fat Diets in Male Wistar Rats. J Nutr 2021:nxab178. [PMID: 34132338 DOI: 10.1093/jn/nxab178] [Reference Citation Analysis]
31 Matsumoto Y, Fujita S, Yamagishi A, Shirai T, Maeda Y, Suzuki T, Kobayashi KI, Inoue J, Yamamoto Y. Brown Rice Inhibits Development of Nonalcoholic Fatty Liver Disease in Obese Zucker (fa/fa) Rats by Increasing Lipid Oxidation Via Activation of Retinoic Acid Synthesis. J Nutr 2021:nxab188. [PMID: 34224565 DOI: 10.1093/jn/nxab188] [Reference Citation Analysis]
32 Meggyesy PM, Masaldan S, Clatworthy SAS, Volitakis I, Eyckens DJ, Aston-Mourney K, Cater MA. Copper Ionophores as Novel Antiobesity Therapeutics. Molecules 2020;25:E4957. [PMID: 33120881 DOI: 10.3390/molecules25214957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Jiang WN, Li D, Jiang T, Guo J, Chen YF, Wang J, Zhou Y, Yang CY, Tang CP. Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance. Chin J Integr Med 2018;24:125-32. [PMID: 27164963 DOI: 10.1007/s11655-016-2252-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
34 Chen EB, Cason C, Gilbert JA, Ho KJ. Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions. J Gastrointest Surg 2018;22:1112-23. [PMID: 29623674 DOI: 10.1007/s11605-018-3755-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
35 Sales RC, Medeiros PC, Spreafico F, de Velasco PC, Gonçalves FKA, Martín-Hernández R, Mantilla-Escalante DC, Gil-Zamorano J, Peres WAF, de Souza SAL, Dávalos A, Tavares do Carmo MG. Olive Oil, Palm Oil, and Hybrid Palm Oil Distinctly Modulate Liver Transcriptome and Induce NAFLD in Mice Fed a High-Fat Diet. Int J Mol Sci 2018;20:E8. [PMID: 30577497 DOI: 10.3390/ijms20010008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
36 Feng MJ, Xie JN, Zhang YX, Tan ZJ, Tang B. Influence of lipid-lowering decoction on hepatic morphology and pathological changes in rats with nonalcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2015; 23(16): 2532-2538 [DOI: 10.11569/wcjd.v23.i16.2532] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Zhang L, Wu X, Liao S, Li Y, Zhang Z, Chang Q, Xiao R, Liang B. Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease. Biol Open 2016;5:1545-52. [PMID: 27659689 DOI: 10.1242/bio.020875] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
38 Ke SH, Zheng CH, Peng C, Zhou Y, Ma W. Establishment of a rat model of non-alcoholic fatty liver disease combined with type 2 diabetes. Shijie Huaren Xiaohua Zazhi 2018; 26(31): 1805-1811 [DOI: 10.11569/wcjd.v26.i31.1805] [Reference Citation Analysis]
39 Green CJ, Pramfalk C, Morten KJ, Hodson L. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. Am J Physiol Endocrinol Metab 2015;308:E1-20. [PMID: 25352434 DOI: 10.1152/ajpendo.00192.2014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
40 Chimienti G, Orlando A, Russo F, D'Attoma B, Aragno M, Aimaretti E, Lezza AMS, Pesce V. The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease. Genes (Basel) 2021;12:1439. [PMID: 34573421 DOI: 10.3390/genes12091439] [Reference Citation Analysis]
41 Manne V, Handa P, Kowdley KV. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clin Liver Dis 2018;22:23-37. [PMID: 29128059 DOI: 10.1016/j.cld.2017.08.007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 16.2] [Reference Citation Analysis]
42 Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: Pathophysiology and clinical implications. Wiley Interdiscip Rev Syst Biol Med. 2020;e1499. [PMID: 32713091 DOI: 10.1002/wsbm.1499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
43 Soret PA, Magusto J, Housset C, Gautheron J. In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. J Clin Med 2020;10:E36. [PMID: 33374435 DOI: 10.3390/jcm10010036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Karatzas T, Sikalias N, Mantas D, Papalois A, Alexiou K, Mountzalia L, Kouraklis G. Histopathological changes and onset of severe hepatic steatosis in rats fed a choline-free diet. Exp Ther Med 2018;16:1735-42. [PMID: 30186395 DOI: 10.3892/etm.2018.6385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Eweis DS, Abed F, Stiban J. Carbon dioxide in carbonated beverages induces ghrelin release and increased food consumption in male rats: Implications on the onset of obesity. Obes Res Clin Pract 2017;11:534-43. [PMID: 28228348 DOI: 10.1016/j.orcp.2017.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Ocker M. Challenges and opportunities in drug development for nonalcoholic steatohepatitis. Eur J Pharmacol 2020;870:172913. [PMID: 31926994 DOI: 10.1016/j.ejphar.2020.172913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Shan W, Gao L, Zeng W, Hu Y, Wang G, Li M, Zhou J, Ma X, Tian X, Yao J. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. Cell Death Dis 2015;6:e1833. [PMID: 26203862 DOI: 10.1038/cddis.2015.196] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 8.0] [Reference Citation Analysis]
48 Sanches SC, Ramalho LN, Augusto MJ, da Silva DM, Ramalho FS. Nonalcoholic Steatohepatitis: A Search for Factual Animal Models. Biomed Res Int. 2015;2015:574832. [PMID: 26064924 DOI: 10.1155/2015/574832] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 14.1] [Reference Citation Analysis]
49 Xiong F, Zheng Z, Xiao L, Su C, Chen J, Gu X, Tang J, Zhao Y, Luo H, Zha L. Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline-Deficient (MCD) Diet-induced Nonalcoholic Steatohepatitis (NASH) Mice. Mol Nutr Food Res 2021;65:e2100067. [PMID: 34047448 DOI: 10.1002/mnfr.202100067] [Reference Citation Analysis]
50 Jump DB, Depner CM, Tripathy S, Lytle KA. Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer. Adv Nutr 2015;6:694-702. [PMID: 26567194 DOI: 10.3945/an.115.009423] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
51 Ballestri S, Nascimbeni F, Romagnoli D, Baldelli E, Lonardo A. The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. Adv Ther 2016;33:291-319. [PMID: 26921205 DOI: 10.1007/s12325-016-0306-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 9.3] [Reference Citation Analysis]
52 Mohammed ED, Abdel-Naim AB, Kangpeng J, Jiang R, Wei J, Sun B. The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. Life Sci 2021;264:118615. [PMID: 33096115 DOI: 10.1016/j.lfs.2020.118615] [Reference Citation Analysis]
53 Ahmad NA, Raizman M, Weizmann N, Wasek B, Arning E, Bottiglieri T, Tirosh O, Troen AM. Betaine attenuates pathology by stimulating lipid oxidation in liver and regulating phospholipid metabolism in brain of methionine‐choline–deficient rats. FASEB j 2019;33:9334-49. [DOI: 10.1096/fj.201802683r] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
54 Gupta K, Song Z, Tang H, Fong E, Ng I, Yu H. 6.28 Liver Tissue Engineering ☆. Comprehensive Biomaterials II. Elsevier; 2017. pp. 491-512. [DOI: 10.1016/b978-0-12-803581-8.10163-8] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
55 Soto-Gutierrez A, Gough A, Vernetti LA, Taylor DL, Monga SP. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems. Exp Biol Med (Maywood). 2017;242:1605-1616. [PMID: 28467181 DOI: 10.1177/1535370217707731] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
56 Delire B, Stärkel P, Leclercq I. Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development. J Clin Transl Hepatol 2015;3:53-66. [PMID: 26357635 DOI: 10.14218/JCTH.2014.00035] [Cited by in Crossref: 72] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
57 Bortolin RC, Vargas AR, Gasparotto J, Chaves PR, Schnorr CE, Martinello KB, Silveira AK, Rabelo TK, Gelain DP, Moreira JCF. A new animal diet based on human Western diet is a robust diet-induced obesity model: comparison to high-fat and cafeteria diets in term of metabolic and gut microbiota disruption. Int J Obes 2018;42:525-34. [DOI: 10.1038/ijo.2017.225] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 14.8] [Reference Citation Analysis]
58 Zhou Y, Wu C, Wang X, Li P, Fan N, Zhang W, Liu Z, Zhang W, Tang B. Exploring the Changes of Peroxisomal Polarity in the Liver of Mice with Nonalcoholic Fatty Liver Disease. Anal Chem 2021;93:9609-20. [PMID: 34191493 DOI: 10.1021/acs.analchem.1c01776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Açıkel Elmas M, Atay N, Bingöl Özakpınar Ö, Arbak S, Kolgazi M, Şener G, Ercan F. Morphological evaluation of the effects of exercise on high-fat-diet-induced liver damage in rats. Turk J Gastroenterol 2020;31:626-32. [PMID: 33090099 DOI: 10.5152/tjg.2020.19638] [Reference Citation Analysis]
60 Faraji S, Hosseini Azar MRM, Alizadeh M. Brewed chicory leaf consumption has unexpected side effects along beneficial effects on liver enzymes in non-alcoholic fatty liver disease patients. Journal of Herbal Medicine 2022;34:100572. [DOI: 10.1016/j.hermed.2022.100572] [Reference Citation Analysis]
61 Croce AC, Ferrigno A, Di Pasqua LG, Berardo C, Piccolini VM, Bertone V, Bottiroli G, Vairetti M. Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models. Journal of Photochemistry and Photobiology B: Biology 2016;164:13-20. [DOI: 10.1016/j.jphotobiol.2016.09.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
62 Yasuno K, Kumagai K, Iguchi T, Tsuchiya Y, Kai K, Mori K. DS-7250, a Diacylglycerol Acyltransferase 1 Inhibitor, Enhances Hepatic Steatosis in Zucker Fatty Rats via Upregulation of Fatty Acid Synthesis. Toxicol Pathol 2018;46:302-11. [PMID: 29587622 DOI: 10.1177/0192623318765909] [Reference Citation Analysis]
63 Toppo E, Al-Dhabi NA, Sankar C, Kumar SN, Buvanesvaragurunathan K, Darvin SS, Stalin A, Balakrishna K, Ceasar SA, Pandikumar P, Ignacimuthu S, Sivasankaran K, Agastian P. Hepatoprotective effect of selected isoandrographolide derivatives on steatotic HepG2 cells and High Fat Diet fed rats. Eur J Pharmacol 2021;899:174056. [PMID: 33753108 DOI: 10.1016/j.ejphar.2021.174056] [Reference Citation Analysis]
64 Al-Wakeel DE, El-Kashef DH, Nader MA. Renoprotective effect of empagliflozin in cafeteria diet-induced insulin resistance in rats: Modulation of HMGB-1/TLR-4/NF-κB axis. Life Sci 2022;:120633. [PMID: 35568226 DOI: 10.1016/j.lfs.2022.120633] [Reference Citation Analysis]
65 Zaman A, Arif Z, Moinuddin, Akhtar K, Ali WM, Alam K. A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. PLoS One 2019;14:e0216736. [PMID: 31116779 DOI: 10.1371/journal.pone.0216736] [Reference Citation Analysis]
66 Álvarez-Mercado AI, Gulfo J, Romero Gómez M, Jiménez-Castro MB, Gracia-Sancho J, Peralta C. Use of Steatotic Grafts in Liver Transplantation: Current Status. Liver Transpl 2019;25:771-86. [PMID: 30740859 DOI: 10.1002/lt.25430] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
67 Kapravelou G, Martínez R, Andrade AM, Nebot E, Camiletti-Moirón D, Aparicio VA, Lopez-Jurado M, Aranda P, Arrebola F, Fernandez-Segura E, Bermano G, Goua M, Galisteo M, Porres JM. Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats. Appl Physiol Nutr Metab 2015;40:1242-52. [PMID: 26509584 DOI: 10.1139/apnm-2015-0141] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
68 Han J, Dzierlenga AL, Lu Z, Billheimer DD, Torabzadeh E, Lake AD, Li H, Novak P, Shipkova P, Aranibar N. Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model. Obesity (Silver Spring). 2017;25:1069-1076. [PMID: 28452429 DOI: 10.1002/oby.21855] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
69 Daniels SJ, Leeming DJ, Detlefsen S, Bruun MF, Hjuler ST, Henriksen K, Hein P, Krag A, Karsdal MA, Nielsen MJ, Brockbank S, Cruwys S. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2020;318:G410-8. [PMID: 31905026 DOI: 10.1152/ajpgi.00066.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Kim S, Hong J, Jeon R, Kim HS. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease. Nutr Res 2016;36:90-100. [PMID: 26773785 DOI: 10.1016/j.nutres.2015.11.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
71 Rodimova S, Elagin V, Karabut M, Koryakina I, Timin A, Zagainov V, Zyuzin M, Zagaynova E, Kuznetsova D. Toxicological Analysis of Hepatocytes Using FLIM Technique: In Vitro versus Ex Vivo Models. Cells 2021;10:2894. [PMID: 34831114 DOI: 10.3390/cells10112894] [Reference Citation Analysis]
72 Daniels SJ, Leeming DJ, Detlefsen S, Bruun MF, Hjuler ST, Henriksen K, Hein P, Karsdal MA, Brockbank S, Cruwys S. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis – Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue. Biomedicine & Pharmacotherapy 2019;111:926-33. [DOI: 10.1016/j.biopha.2018.12.130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
73 Martínez R, Kapravelou G, Donaire A, Lopez-Chaves C, Arrebola F, Galisteo M, Cantarero S, Aranda P, Porres JM, López-Jurado M. Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats. Food Funct 2018;9:830-50. [PMID: 29364302 DOI: 10.1039/c7fo01790a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
74 Zhai T, Xu W, Liu Y, Qian K, Xiong Y, Chen Y. Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway. Oxid Med Cell Longev 2020;2020:2313641. [PMID: 33354276 DOI: 10.1155/2020/2313641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Fukuda A, Sasao M, Asakawa E, Narita S, Hisano M, Suruga K, Ichimura M, Tsuneyama K, Tanaka K, Omagari K. Dietary fat, cholesterol, and cholic acid affect the histopathologic severity of nonalcoholic steatohepatitis in Sprague-Dawley rats. Pathology - Research and Practice 2019;215:152599. [DOI: 10.1016/j.prp.2019.152599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
76 Elsayed HRH, El-Nablaway M, Khattab BA, Sherif RN, Elkashef WF, Abdalla AM, El Nashar EM, Abd-Elmonem MM, El-Gamal R. Independent of Calorie Intake, Short-term Alternate-day Fasting Alleviates NASH, With Modulation of Markers of Lipogenesis, Autophagy, Apoptosis, and Inflammation in Rats. J Histochem Cytochem 2021;69:575-96. [PMID: 34448436 DOI: 10.1369/00221554211041607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Singh C, Prakash C, Mishra P, Tiwari KN, Mishra SK, More RS, Kumar V, Singh J. Hepatoprotective efficacy of Premna integrifolia L. leaves against aflatoxin B1-induced toxicity in mice. Toxicon 2019;166:88-100. [DOI: 10.1016/j.toxicon.2019.05.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
78 Yang W, He Y, Liu S, Gan L, Zhang Z, Wang J, Liang J, Dong Y, Wang Q, Hou Z, Yang L. Integrative transcriptomic analysis of NAFLD animal model reveals dysregulated genes and pathways in metabolism. Gene 2016;595:99-108. [PMID: 27697615 DOI: 10.1016/j.gene.2016.09.047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
79 Bier A, Khasbab R, Haberman Y, Braun T, Hadar R, Sosnovski K, Amir A, Leibowitz A, Grossman E. Antibiotic Treatment Does Not Ameliorate the Metabolic Changes in Rats Presenting Dysbiosis After Consuming a High Fructose Diet. Nutrients 2020;12:E203. [PMID: 31941016 DOI: 10.3390/nu12010203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
80 Liu X, Xie ZH, Liu CY, Zhang Y. Effect of Chinese Herbal Monomer Hairy Calycosin on Nonalcoholic Fatty Liver Rats and its Mechanism. Comb Chem High Throughput Screen 2019;22:194-200. [PMID: 30973105 DOI: 10.2174/1386207322666190411112814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 Carvajal S, Perramón M, Oró D, Casals E, Fernández-Varo G, Casals G, Parra M, González de la Presa B, Ribera J, Pastor Ó, Morales-Ruíz M, Puntes V, Jiménez W. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. Sci Rep 2019;9:12848. [PMID: 31492960 DOI: 10.1038/s41598-019-49262-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
82 [DOI: 10.1101/2020.07.14.203166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
83 Handayani D, Febrianingsih E, Desi Kurniawati A, Kusumastuty I, Nurmalitasari S, Widyanto RM, Oktaviani DN, Maghfirotun Innayah A, Sulistyowati E. High-fructose diet initially promotes increased aortic wall thickness, liver steatosis, and cardiac histopathology deterioration, but does not increase body fat index. J Public Health Res 2021;10. [PMID: 33855398 DOI: 10.4081/jphr.2021.2181] [Reference Citation Analysis]
84 Grasselli E, Canesi L, Portincasa P, Voci A, Vergani L, Demori I. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine. Annals of Hepatology 2017;16:707-19. [DOI: 10.5604/01.3001.0010.2713] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
85 Ngamlerst C, Udomkasemsab A, Kongkachuichai R, Kwanbunjan K, Chupeerach C, Prangthip P. The potential of antioxidant-rich Maoberry (Antidesma bunius) extract on fat metabolism in liver tissues of rats fed a high-fat diet. BMC Complement Altern Med 2019;19:294. [PMID: 31684925 DOI: 10.1186/s12906-019-2716-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
86 Neri AA, Dontas IA, Iliopoulos DC, Karatzas T. Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis. In Vivo 2020;34:953-64. [PMID: 32354880 DOI: 10.21873/invivo.11863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Oligschlaeger Y, Shiri-Sverdlov R. NAFLD Preclinical Models: More than a Handful, Less of a Concern? Biomedicines 2020;8:E28. [PMID: 32046285 DOI: 10.3390/biomedicines8020028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
88 Rodrigues AA, Andrade RSB, Vasconcelos DFP. Relationship between Experimental Diet in Rats and Nonalcoholic Hepatic Disease: Review of Literature. Int J Hepatol 2018;2018:9023027. [PMID: 30515333 DOI: 10.1155/2018/9023027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
89 Lin C, Huang X, Liu H, Wang Y. Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact. Dig Dis Sci 2015;60:3513-24. [DOI: 10.1007/s10620-015-3772-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
90 Jeong HJ, Lee SH, Kang HE. Changes in digoxin pharmacokinetics associated with hepatic P-glycoprotein upregulation in rats with non-alcoholic fatty liver disease. Fundam Clin Pharmacol 2021. [PMID: 33914974 DOI: 10.1111/fcp.12687] [Reference Citation Analysis]
91 Boyce G, Shoeb M, Kodali V, Meighan T, Roberts JR, Erdely A, Kashon M, Antonini JM. Using liquid chromatography mass spectrometry (LC-MS) to assess the effect of age, high-fat diet, and rat strain on the liver metabolome. PLoS One 2020;15:e0235338. [PMID: 32609782 DOI: 10.1371/journal.pone.0235338] [Reference Citation Analysis]
92 Muriel P, López-Sánchez P, Ramos-Tovar E. Fructose and the Liver. Int J Mol Sci 2021;22:6969. [PMID: 34203484 DOI: 10.3390/ijms22136969] [Reference Citation Analysis]
93 Sikalias N, Karatzas T, Alexiou K, Mountzalia L, Demonakou M, Kostakis ID, Zacharioudaki A, Papalois A, Kouraklis G. Intermittent Ischemic Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury and Extensive Hepatectomy in Steatotic Rat Liver. J Invest Surg. 2018;31:366-377. [PMID: 28644700 DOI: 10.1080/08941939.2017.1334844] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
94 Saito T, Muramatsu M, Ishii Y, Saigo Y, Konuma T, Toriniwa Y, Miyajima K, Ohta T. Pathophysiological analysis of the progression of hepatic lesions in STAM mice. Physiol Res 2017;66:791-9. [PMID: 28730823 DOI: 10.33549/physiolres.933592] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
95 Savari F, Mard SA, Badavi M, Rezaie A, Gharib-Naseri MK. A new method to induce nonalcoholic steatohepatitis (NASH) in mice. BMC Gastroenterol 2019;19:125. [PMID: 31307427 DOI: 10.1186/s12876-019-1041-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
96 Pastor CM, Vilgrain V. Steatosis Alters the Activity of Hepatocyte Membrane Transporters in Obese Rats. Cells 2021;10:2733. [PMID: 34685713 DOI: 10.3390/cells10102733] [Reference Citation Analysis]
97 Elsayed HRH, El-Nablaway M, Othman BH, Abdalla AM, El Nashar EM, Abd-Elmonem MM, El-Gamal R. Can Dasatinib Ameliorate the Hepatic changes, Induced by Long Term Western Diet, in Mice? Ann Anat 2021;234:151626. [PMID: 33144268 DOI: 10.1016/j.aanat.2020.151626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Antonini JM, Kodali V, Shoeb M, Kashon M, Roach KA, Boyce G, Meighan T, Stone S, Mckinney W, Boots T, Roberts JR, Zeidler-erdely PC, Erdely A. Effect of a High-Fat Diet and Occupational Exposure in Different Rat Strains on Lung and Systemic Responses: Examination of the Exposome in an Animal Model. Toxicological Sciences 2020;174:100-11. [DOI: 10.1093/toxsci/kfz247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
99 Sherriff JL, O'Sullivan TA, Properzi C, Oddo JL, Adams LA. Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. Adv Nutr 2016;7:5-13. [PMID: 26773011 DOI: 10.3945/an.114.007955] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 15.2] [Reference Citation Analysis]
100 Sámano-Hernández L, Fierro R, Marchal A, Guéant JL, González-Márquez H, Guéant-Rodríguez RM. Beneficial and deleterious effects of sitagliptin on a methionine/choline-deficient diet-induced steatohepatitis in rats. Biochimie 2021;181:240-8. [PMID: 33333172 DOI: 10.1016/j.biochi.2020.12.004] [Reference Citation Analysis]
101 Tokoro M, Gotoh K, Kudo Y, Hirashita Y, Iwao M, Arakawa M, Endo M, Oribe J, Masaki T, Honda K, Kakuma T, Seike M, Murakami K, Shibata H. α-Tocopherol suppresses hepatic steatosis by increasing CPT-1 expression in a mouse model of diet-induced nonalcoholic fatty liver disease. Obes Sci Pract 2021;7:91-9. [PMID: 33680496 DOI: 10.1002/osp4.460] [Reference Citation Analysis]
102 Zhao L, Cang Z, Sun H, Nie X, Wang N, Lu Y. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. BMC Endocr Disord 2017;17:13. [PMID: 28241817 DOI: 10.1186/s12902-017-0165-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]